BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21720905)

  • 21. Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial.
    Kramer JJ; Gu L; Moreira D; Andriole G; Csizmadi I; Freedland SJ
    J Urol; 2022 Feb; 207(2):417-423. PubMed ID: 34544265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship among diet habit and lower urinary tract symptoms and sexual function in outpatient-based males with LUTS/BPH: a multiregional and cross-sectional study in China.
    Chen Y; Yu W; Zhou L; Wu S; Yang Y; Wang J; Tian Y; He D; Xu Y; Huang J; Wang X; Gao X; Li H; Ma L; Zhang N; Zhao S; Jin X
    BMJ Open; 2016 Aug; 6(8):e010863. PubMed ID: 27580828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
    Park JS; Koo KC; Kim HK; Chung BH; Lee KS
    Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle and Progression of Lower Urinary Tract Symptoms in German Men-Results From the EPIC-Heidelberg Cohort.
    Rohrmann S; Katzke VA; Kaaks R
    Urology; 2018 Oct; 120():192-196. PubMed ID: 29940234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.
    Chandra Engel J; Palsdottir T; Aly M; Egevad L; Grönberg H; Eklund M; Nordström T
    Scand J Urol; 2020 Feb; 54(1):1-6. PubMed ID: 31876229
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW).
    Barqawi A; O'Donnell C; Kumar R; Koul H; Crawford ED
    Int J Impot Res; 2005; 17(4):370-4. PubMed ID: 15889121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
    Egan KB
    Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey.
    Boeri L; Capogrosso P; Ventimiglia E; Serino A; La Croce G; Russo A; Castagna G; Scano R; Briganti A; Damiano R; Montorsi F; Salonia A
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):376-81. PubMed ID: 26415556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index?
    Choi J; Ikeguchi EF; Lee SW; Choi HY; Te AE; Kaplan SA
    Eur Urol; 2002 Jul; 42(1):7-11. PubMed ID: 12121722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia.
    Lee D; Koo KC; Yoo JW; Lee KS
    Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Chisari M; Castelli T; Favilla V; Morgia G
    World J Urol; 2015 May; 33(5):743-51. PubMed ID: 25189458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.